TY - JOUR
AU - K . Y. Xu
AU - A. K. Gertner
AU - S. F. Greenfield
AU - A. R. Williams
AU - R. A. Grucza
A1 - 
AD - Department of Psychiatry, Health and Behavior Research Center, Washington University School of Medicine, Renard Hospital 3007A, 4940 Children's Place, Saint Louis, MO, 63110, USA. xukeviny@wustl.edu.; University of North Carolina Hospitals, Chapel Hill, NC, USA.; Division of Women's Mental Health and Division of Alcohol, Drugs, and Addiction, McLean Hospital, Belmont, MA, USA.; Department of Psychiatry, Harvard Medical School, Boston, MA, USA.; Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY, USA.; Division of Substance Use Disorders, New York State Psychiatric Institute, New York, NY, USA.; Advanced Health Data Institute, Department of Health and Outcomes Research, Department of Family/Community Medicine, Saint Louis University School of Medicine, St. Louis, MO, USA.
AN - 38493109
BT - Addict Sci Clin Pract
C5 - Opioids & Substance Use; Financing & Sustainability; Healthcare Disparities
CP - 1
DA - Mar 16
DO - 10.1186/s13722-024-00450-0
DP - NLM
ET - 20240316
IS - 1
JF - Addict Sci Clin Pract
LA - eng
PY - 2024
SN - 1940-0632 (Print); 1940-0632
SP - 17
ST - Treatment setting and buprenorphine discontinuation: an analysis of multi-state insurance claims
T1 - Treatment setting and buprenorphine discontinuation: an analysis of multi-state insurance claims
T2 - Addict Sci Clin Pract
TI - Treatment setting and buprenorphine discontinuation: an analysis of multi-state insurance claims
U1 - Opioids & Substance Use; Financing & Sustainability; Healthcare Disparities
U3 - 10.1186/s13722-024-00450-0
VL - 19
VO - 1940-0632 (Print); 1940-0632
Y1 - 2024
ER -